You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -9,941.0% | -4,880.0% |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -1.9 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 172.5 | 140.2 |
| Price / Book value | 1.8 |
| Latest | Forecast | |
|---|---|---|
| Revenue | -46.0% | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2014-12-31 | 0.18 | -3.34 | -3.43p | -14.9 | 0.0 | n/a | n/a | 0.0% |
| 2015-12-31 | 0.08 | -4.55 | -4.40p | -6.8 | 0.0 | n/a | n/a | 0.0% |
| 2016-12-31 | 0.16 | -6.31 | -4.54p | -11.5 | 0.0 | n/a | n/a | 0.0% |
| 2017-12-31 | 0.15 | -7.00 | -4.75p | -35.8 | 0.0 | n/a | n/a | 0.0% |
| 2018-12-31 | 0.08 | -7.96 | -5.19p | -2.3 | 0.0 | n/a | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2019-12-31 | 0.10 | -4.88 | -2.87p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| 2020-12-31 | 0.10 | -5.11 | -2.76p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| ImmuPharma pleased with Lupuzor open-label study results Sharecast News | 28 Jun |
|---|---|
| Immupharma raises £2.66m from subscription agreement with institutional investor Sharecast News | 26 Jun |
| ImmuPharma seeks route forward for lupus treatment as losses mount Sharecast News | 24 May |
| TR-1: notification of major holdings | 04-Jul-19 07:04 |
|---|---|
| TR-1: notification of major holdings | 02-Jul-19 15:34 |
| Update on Lupuzor | 28-Jun-19 07:06 |
| 2019 Annual General Meeting | 27-Jun-19 13:39 |
| Subscription to raise £2.66 million | 26-Jun-19 07:04 |